Clinical Trials Logo

Citation(s)

An Open, Single Center Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of Two Ascending Doses of the Candidate Vaccine MVA-MERS-S

Details for clinical trial NCT03615911